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Abstract
The Nursing, Midwifery and Allied Health Professions Research Unit (NMAHP RU) is 
funded by the Chief Scientist Office of the Scottish Government Health Directorates, and 
is co-hosted by Glasgow Caledonian University and the University of Stirling. A key 
component of its focus is supporting evidence-based healthcare by undertaking research 
on issues related to urogenital disorders in males and females, including pelvic organ 
prolapse, lower urinary tract symptoms (LUTS) and sexual dysfunction. These areas have 
been understudied and robust research is lacking. Yet they are frequently identified by 
clinicians, researchers, patients and carers as significantly impacting the quality of life of 
those affected. In consideration of the lack of evidence, and in a quest for researchable 
topics for subsequent years, the Urogenital Disorders programme of NMAHP RU hosted 
an expert group of clinicians and researchers to help establish a research agenda and 
priorities for funding. The following report describes the process and the outcomes from 
the group's deliberations, with reflections from an international perspective.
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Introduction
The Nursing, Midwifery and Allied Health Professions Research Unit (NMAHP RU) is funded 
by the Chief Scientist Office of the Scottish Government Health Directorates, and is co-hosted by 
Glasgow Caledonian University and the University of Stirling.  A key component of its focus is
supporting evidence-based healthcare by undertaking research on issues related to urogenital 
disorders in males and females, including pelvic organ prolapse, lower urinary tract symptoms
(LUTS) and sexual dysfunction.  These areas have been understudied and robust research is 
lacking. Yet they are frequently identified by clinicians, researchers, patients and caregivers as 
significantly impacting the quality of life of those affected.  In consideration of the lack of 
evidence, and in a quest for researchable topics for subsequent years, the Urogenital Disorders 
program of NMAHP RU hosted an expert group of clinicians and researchers to help establish a 
research agenda and priorities for funding.  The following report describes the process and the 
outcomes from the group’s deliberations, with reflections from an international perspective.  
Establishing research goals
Experts in continence product evaluation, pelvic floor muscle therapy, LUTS in adults, and 
sexuality from the fields of nursing, physiotherapy, medicine, counseling, health services research
and consumer involvement in research were invited to join and attend an introductory meeting of 
the Urogenital Research Group for Nursing and the Therapies (URGENT) (Box 1).  In 
preparation for the meeting, selected experts were asked to prepare a short presentation based on 
a comprehensive review of the literature on an assigned topic.  This included a discussion of what 
is known and what needs to be known in terms of research evidence on the topic, and a list of 
questions which could shape future research.  Each topic had a maximum of four 10 minute 
presentations.  The four broad topic areas were:
1. conservative management of pelvic organ prolapse;
2. conservative management of LUTS;
3. conservative management of sexual dysfunction, and;
4. consumer involvement in research programs.
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The criteria used by the group to establish research priorities were informed by the research 
policy of NMAHP RU, which has an emphasis on clinical rather than bench research.  The group 
considered the strength of evidence, personal impact of the problem, current known research 
occurring in the field, and the existence of measurable and clinically relevant outcome measures. 
At the end of each topic session, small group discussions took place which considered the ranking 
of the potential ideas for further research.  
A modified Delphi consensus-building approach was used to identify and prioritize research 
questions within each of the topic areas.  At the end of all presentations, further ranking of all the 
questions was undertaken and each small group presented their rationale for the choice of the key 
areas for further study (Table 1). Discussion occurred on potential partnerships with other 
disciplines and funding opportunities.  The following report highlights the prioritized questions, 
summarizing the associated research evidence and the research recommendations made.  
Pelvic Organ Prolapse: What is known
Pelvic organ prolapse (POP) is the descent from the normal anatomical position of some part of 
the female pelvic organs, due to herniation through deficient pelvic fascia, or weaknesses or 
deficiencies in the ligaments or muscles which should support the pelvic organs.  Vaginal 
delivery and chronic increases in intra-abdominal pressure (chronic constipation, obesity, chronic 
coughing and repetitive heavy lifting) are thought to be the main risk factors for prolapse.  
Symptoms associated with prolapse include a sensation of something coming down in the vagina, 
LUTS, bowel and sexual dysfunction, and abdominal pain and back ache.  The condition is 
common: 40 to 50% of all women over 40 years of age are likely to have some degree of 
prolapse.1,2  The main conservative treatment options are: physical therapy such as pelvic floor 
muscle training (PFMT), insertion of mechanical device (e.g. vaginal pessary) and lifestyle 
changes such as losing weight or reducing constipation.
Pelvic floor muscle training for prolapse
Referral of women with prolapse for physiotherapy has become common in many centers.  The 
recently updated Cochrane review on this topic3 found some weak evidence in favor of PFMT, 
particularly for women with anterior prolapse, but the trials were small4 or of poor quality5, 
making the conclusions tentative at best.
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In one feasibility study6, 47 women with prolapse of stage I or II were randomized to either a 
PFMT intervention or to a control group.  The intervention group had significantly greater
reductions in prolapse stage and were significantly more likely to say their prolapse had improved 
since the start of the study.  Follow-up was only 6 months and durability of the results is not 
known.
A general issue regarding PFMT is the lack of agreement as to the optimum regimen. The 
Cochrane reviews7,8, which found PFMT in women with stress urinary incontinence to be 
effective, could not identify an optimum training regimen.  Over the last 10 years the theories of 
pelvic floor function have changed. It is now widely accepted that the pelvic floor muscles do not 
work in isolation, and that other muscles, in particular transverses abdominus, also play a key 
role.9,10 However, Bø and Sherburn11 argue that exercises should be specific to the pelvic floor 
muscles as this produces the optimum training effect. Further research is required to identify an 
optimum training regimen for the pelvic floor muscles. This research also needs to include 
developing improved techniques such as the use of dynamic ultrasound, to identify these muscles 
accurately and to be able to assess their function.
Vaginal pessaries for prolapse
A wide array of support and space-occupying pessaries is available in the USA. In many areas of 
the UK, only the ring pessary (support) and the shelf pessary (space-occupying) are readily 
available.  There are few published data on the use of pessaries for the treatment of prolapse and 
there is no consensus on optimal pessary management, including frequency of change and use of 
antiseptics or estrogen creams.  Pessary success rates are reported to be between 9 and 73% 
depending on the definition of success and the duration of follow-up (1 week to 3 years).12-19
Severity of prolapse was not found to predict pessary success in any of the studies.  The 
retrospective design in some of these studies, variation in pessaries used and patient selection 
make it difficult to compare results. Some researchers found that women with previous prolapse 
surgery, previous hysterectomy or pre-existing stress urinary incontinence were less likely to 
have success with pessary treatment.15,16,18,19 Clemons et al. were unable to demonstrate a 
significant association between past prolapse surgery and pessary failure but did find that those
with shorter vaginas and wider introituses were more likely to fail.12 Hanson et al. reported that 
women on hormone replacement therapy (HRT) were more likely to succeed with pessaries but 
half of the women studied suffered predominantly with urinary incontinence rather than pelvic 
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organ prolapse.14   There is some evidence that spontaneous regression of prolapse may occur 
around the menopause or with the use of vaginal pessaries.20-22
Pelvic Organ Prolapse: Recommendations for research
PFMT
 A rigorous, adequately-powered randomized controlled trial of pelvic floor muscle 
training is needed.  Two such trials are now underway: one in the UK23 and one in 
Norway.24
 Investigation of the role of pelvic floor exercises in conjunction with surgery, and 
mechanical devices is needed.
 Studies are required to identify the optimum pelvic floor muscle training regimen to 
guide practice and standardize protocols.
Pessaries
 Studies are needed to evaluate the optimal pessary-fitting protocol, the types and numbers 
of pessaries to try, change protocols, and whether topical HRT improves outcomes.
 A comprehensive survey is needed to establish the types of pessaries readily available in 
different regions in the UK and in different care settings (i.e. primary, secondary and 
tertiary units) and the rationale for choice of type.
Lower Urinary Tract Symptoms (LUTS): what is known
LUTS are common and affect people of all ages. Considering urinary incontinence alone, 
information available from the Department of Health suggests that 5% to 14% of women and 3% 
of men aged 25 to 44 years who live at home suffer from this condition.25  For those living in 
institutions, the prevalence is estimated to be far higher (33% in residential homes, 67% in 
nursing homes and upwards of 50% in care of the elderly/elderly mental health wards.)25
Long Term Indwelling Catheterization
One management strategy for intractable LUTS is an indwelling catheter.  Indwelling urinary 
catheterization carries a known risk of urinary tract infection (UTI). Silver alloy catheters are 
coated with silver ions, which inhibit biofilm formation, and are claimed to reduce UTIs. There 
is some evidence that using silver coated indwelling catheters in hospitalized adults delays the 
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onset of catheter acquired UTI in the short-term, and that a role exists for these products in 
intensive care settings where compromised health status could be negatively affected by the 
development of a UTI 26-28. What is not understood is whether there is a role for silver alloy
catheters for selected patients who have a long term indwelling catheter.
‘Trial without Catheter’
A ‘trial without catheter’ (TWOC) is a common procedure of removing a catheter and assessing 
whether the individual is fully emptying their bladder prior to permanent removal. Generally, the 
criteria for a successful TWOC are good control of voiding, passing adequate volumes of urine, 
and a low post void residual. Some centers advocate saline instillation prior to removing the 
catheter but this practice has not been evaluated in a manner that enables clinicians to develop 
evidence-based policies. Current evidence is limited to two small trials comparing both methods 
(saline infusion and no saline infusion) in the postoperative urology patient. 29-30 The results
suggest that the infusion method is safe and simple and can help in the assessment of voiding and 
increasing readiness for discharge. In addition to this, Kleeman et al’s study of voiding efficiency 
after urogynecological surgery, found that by calculating post void residual after saline 
instillation, voiding efficiency could be predicted in 93% of patients who voided >50% of the 
amount inserted and in 100% of patients who voided >68%.31
LUTS: Recommendations for further research
 Research is required which explores long term use of indwelling silver alloy catheters,
and includes outcomes such as symptomatic UTI with pyuria,  adverse effects, 
development of antibiotic resistance and economic implications.
 A large randomized controlled trial is needed of the practice of instillation of normal 
saline into the bladder prior to removal and trial of voiding, to assess impact on 
predicting voiding efficiency and to evaluate time, cost and patient satisfaction.
Sexual dysfunction: What is known
Sexual function plays an important part in a person’s overall health and well-being.  Sexual 
dysfunction therefore can have a profound effect on quality of life.  The factors contributing to 
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sexual problems are many: physical or mental illness, surgery, medication side effects.  A 
combination of physical and psychological causes is common.
Male sexual dysfunction
About 20-30% of adult men may have at least one manifest of sexual dysfunction 32.  Male sexual 
dysfunction includes problems with erection, ejaculation, orgasmic sensation and sexual drive.  
Erectile dysfunction was defined by a National Institutes of Health Consensus Development 
Conference as “the inability to achieve an erection sufficient for satisfactory sexual performance 
(for both partners)”.  The prevalence of erectile dysfunction is however unknown. Aytac et al 
have estimated that 152 million men worldwide were suffering from erectile dysfunction in 1995, 
a figure projected to rise to 322 million by 2025.33  Conservative treatment options for erectile 
dysfunction include vacuum devices, pelvic floor exercises, counseling and sex therapy and 
lifestyle modifications used alone or in combination with medical treatments.  In one trial 
comparing the effectiveness of pelvic floor muscle exercises, manometric biofeedback and 
lifestyle changes for erectile dysfunction with lifestyle changes only 40% of men in the pelvic 
floor muscle exercises group attained normal erectile function, 35% improved, and 26% failed to 
improve. 34 These results compared favorably with the results from one trial for men of similar 
etiology using sildenafil (Viagra) .35
Female sexual dysfunction
About 40-45% of women are affected by sexual dysfunction.32  Dyspareunia, vaginismus, 
orgasmic dysfunction, disorders of desire and sexual arousal problems are the main female sexual 
dysfunctions.  Specific treatments for these disorders include Masters and Johnson’s sensate 
focus exercises, relaxation, pelvic floor exercises and instruction in the use of vaginal dilators.  
Clinical practice suggests such treatments are most effective when delivered in conjunction with 
psychotherapy interventions.  There is limited evidence however of the efficacy of some of these 
approaches.  In particular, there is a paucity of evidence for: the effectiveness of treatments for 
vaginismus36 and vulvodynia; the benefits to women of using both medical and behavioral
interventions for dyspareunia; or the effectiveness of pelvic floor exercises for most female 
sexual dysfunctions.
Sexual dysfunction: Recommendations for research
Male
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 Rather than the focus being on the organic deficit, research should be holistic and should 
consider the broader effects of the problem and its treatment e.g. on relationships, family, 
employment and social interaction.
 A large multi-centered randomized controlled trial is warranted into the effectiveness of 
clinic-taught pelvic floor exercises for men with erectile dysfunction.
 Research is needed into partner issues, in particular how erectile dysfunction affects 
partners.
Female
 Trials are needed into the effects of individual and integrated treatment options for 
vaginismus and vulvodynia.  It is crucial that such studies have a control group, are 
randomized and use recognized objective outcome measures.
 Large multi-centered randomized controlled trials are needed to fully investigate the role 
of pelvic floor muscle training, which is costly in terms of therapist time, for the 
treatment of many female sexual dysfunctions (e.g. anorgasmia, vaginismus).
 For women with post operative dyspareunia, studies are needed to explore how to balance 
the immediate physical side effects of surgery with longer term sexual dysfunction.
Consumer involvement in the planning and conduct of health care research: what is known
There are ethical reasons for involving consumers in the planning and conduct of health care 
research: consumers are certainly stakeholders in health care and, as taxpayers, are also funders.  
There are also practical benefits: with experience of the conditions and services affecting them, 
consumers can identify outcomes of importance, inform the design of research procedures and 
materials, and identify the information and support needs of potential research participants 37.
Involving consumers in research in a constructive and effective way is not simple, however.  The 
appropriateness of sources must be considered: consumer perspectives constitute a complex 
spectrum, ranging from experiences relating to conditions or treatments expressed by individuals,
to priorities relating to services expressed by society as a whole. While it might be appropriate for 
one or two consumers to assist in the development of materials for a study, in many other 
contexts more representative views are required and consideration must be given to undeclared 
agenda and conflicts of interest.  The methods used for gathering consumer views and factoring 
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them into the research process also need careful consideration as does the stage of the research 
process at which consumer involvement is most effective. 
The potential of consumer involvement in research to improve its effectiveness and ability to 
answer questions of importance to both consumers and practitioners is considerable.  However, to 
date there has been greater emphasis on the “why” of consumer involvement than the “how”, so 
that researchers often must develop consumer involvement policies from scratch.  The resultant 
danger is that consumer involvement may lessen the methodological integrity of research and 
ultimately the authority of the evidence base.  
Consumer involvement in the planning and conduct of health care research: 
Recommendations for research
 A body of evidence relating to consumer involvement in research should be developed.
 Appropriate and effective methods of consumer involvement may be identified study by 
study, but unless they are reported, there is little opportunity for the methodology of 
consumer involvement to be developed.
 It is essential that the strengths and limitations of methods of consumer involvement in 
research activities to date be reported and published. 
Commentary
The purpose of the research consensus day was to identify areas of practice in urogenital health 
requiring further investigation and to prioritize questions for clinical research.  Questions 
concerning practice dominated - a focus that reflected the group composition of predominantly 
clinicians.   For example, pragmatic questions comparing silver alloy indwelling catheters versus 
non silver in long term care were raised, but challenges on implementing current evidence or
obtaining meaningful outcome measures required more mutual discussion and would be a topic 
for further research seminars.
The day ended with people energized and excited about research opportunities.  All in attendance 
agreed on the necessity for more time together as a group to consider the real issues in evidence 
based practice, including clinicians attempting to utilize evidence and researchers trying to find 
the evidence to inform practice. Further questions need debating. Is the continuing quest for 
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more evidence a misapplication of research energies? Do gaps in the evidence base which are 
most important to clinicians and patients alike remain unidentified? Is it more important to 
explore the reasons why current evidence is not initiated into practice than to keep adding to a 
pool of information which is not applied? A good example concerns the use of intermittent 
catheterization (IC) by community dwelling individuals.  Based on the current supporting 
evidence, the North American experience involves IC as a typically clean procedure with reused 
PVC catheters that are washed by the user with soap and water and air-dried.  However, in 
Europe, stricter protocols are adhered to and many patients use single use hydrophilic catheters.  
Is one method better? What does the published research suggest? In what context are the 
decisions made for either technique? Who influences the decision making to use one product over 
another? A recent systematic review suggests there is no significant difference between products 
but concludes, frustratingly, with the statement that further well-designed randomized controlled 
trials are necessary.38,39
In clinical research, important findings are slow to reach the practitioners and even slower to 
effect change.  A key example is the treatment of asymptomatic bacteriuria in patients with long-
term indwelling catheters.  Although routine urine cultures are no longer part of care (based on 
the evidence that all patients with indwelling catheters will be colonized after 30 days of 
catheterization), there remain many who are tested and as a result treated with antibiotics for 
vague issues such as odor, leaking around the catheter, urethral discharge or meatal irritation.  
These are common catheter-related problems and despite the knowledge that antibiotics are rarely
effective in providing relief for them, urinalyses are done and patients are unnecessarily treated.  
The knowledge about best practice in catheter care exists. Unfortunately the knowledge is not 
well applied, resulting in practice that is less than optimum and not evidence-based (and costly!).  
According to Jeremy Grimshaw and colleagues 40 knowledge may be the least of the issues 
affecting evidence based practice.  He argues that lack of knowledge forms less of a barrier to 
evidence-based practice than institutional resistance from within organizational settings, peer 
group attitudes among professionals, uncritical educational norms, and poorly informed 
consumer-generated patient demand.
How do researchers and clinicians overcome the lack of research utilization? It has long been 
realized that the traditional dissemination practice by researchers of publishing and presenting 
findings at peer reviewed conferences does little to change practice.  Yet Universities reward 
faculty for these endeavors rather than reward them for work at the clinical level where the 
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research findings should have more direct relevance. Do researchers have a duty to be more 
involved in the direct clinical dissemination of their work? Is one research study enough to 
change practice or should more replication trials be conducted to support or refute the findings of 
the original study?  And might more replications serve to put research into clinical practice itself? 
Replication studies may pose challenges for researchers if funding bodies prefer to support new 
and original research; strong arguments may be necessary to convince funders that replication 
studies are required to support the evidence base.  New research grows out of well-conducted 
replication as a result of which more questions are certain to arise.  
Another consideration is that a mismatch exists in many areas between the questions that are 
addressed by clinical and health services research and the questions which practicing clinicians 
and health care consumers need answered 41 . If research resources are to be used effectively it is 
important that they are directed at the many uncertainties about treatment and management which 
are of practical, day-to-day clinical importance but which cannot currently be answered by up-to-
date research evidence. The work of groups such as URGENT and of organizations such as The 
James Lind Alliance, which helps clinicians and patients to work together to identify and 
prioritize important gaps in the evidence base, is of importance in addressing this issue.
A key agreement among participants centered on the necessity for “further research” in all areas 
of conservative management of urinary incontinence or urogenital problems.  This gathering of 
experts and researchers facilitated some important debates on issues of clinical concern.  All 
participants left the day with a sense that opportunities were just beginning for further critical 
studies which would enhance clinical decision-making.  Outstanding questions for further 
exploration were raised and the researchers in the group were challenged to implement some of 
the studies.  However the researchers were also left with a task of major proportions: reviewing 
the current evidence, writing research proposals, and applying for funding in the highly 
competitive market.  Moreover, underlying theoretical assumptions related to research questions 
deserve much deeper consideration.
In conclusion, the group raised many more questions than answers for researchers and clinicians 
alike.  Such energizing discussion should go far to encourage thoughtful consideration of practice 
patterns, to help healthcare professionals see research findings as related to the real clinical world 
where practice does not change rapidly (for good reason in many cases), and to assist in planning 
further strategic meetings at which research utilization is addressed in a spirit of critical question 
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and possibility. Further meetings of the group should include deeper exploration of these key 
issues. 
Key points:
The URGENT Workshop identified some key research recommendations in several 
clinical areas.
The need for clinicians and patients from different areas within continence care and 
urogenital health to work together to identify barriers to improved evidence based 
practice was underlined.
Some key questions relating to evidence based practice in continence care and urogenital 
health need to be carefully considered: 
 why is some robust research evidence not factored into clinical practice?
 what questions of everyday clinical importance to clinicians and patients alike remain 
unanswered by research?
 why is the same evidence base interpreted differently in separate regions of the world?
 is institutional resistance, clinician conservatism, and poorly informed patient pressure more 
serious barriers to evidence-based medicine that a paucity of evidence?
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Box 1. Members of the Urogenital Research Group for Nursing and the Therapies
Name Position Facility
Dr Nadia Ali SPR Gynecology Hope Hospital, Manchester
Dr Brian Buckley Chairman Incontact
Mrs Libby Coats Psychosexual Therapist Sandyford Initiative, 
Glasgow
Prof Grace Dorey Professor of Physiotherapy 
(Urology)
University of West of 
England, Bristol
Dr Mandy Fader Reader in Nursing University of Southampton
Dr Cathryn Glazener Senior Clinical Research Fellow Health Services Research 
Unit, Aberdeen
Ms Narelle Gregor Research Facilitator Western General Hospital, 
Edinburgh
Dr Suzanne Hagen Program Leader, Urogenital 
Disorders
NMAHP Research Unit




Mr Brian McGlynn Specialist Nurse Urology/Oncology Ayr Hospital
Ms Michelle McGradie Nurse Practitioner Western General Hospital, 
Edinburgh
Ms Susanne McPhee Continence Sister Ayr Hospital
Prof Katherine Moore Professor & Associate Dean 
Graduate Studies Faculty of 
Nursing
University of Alberta, Canada
Prof Kate Niven Director NMAHP Research Unit
Mr Derek Rutherford Specialist Urology Nurse - Sexual 
Medicine
Ayr Hospital
Ms Lesley Sinclair Research Fellow, Urogenital 
Disorders
NMAHP Research Unit
Ms Diane Stark Superintendent Physiotherapist Southern General Hospital, 
Glasgow
Ms Katie Taylor Clinical Nurse Specialist Liverpool Women's Hospital
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Table 1  Research questions identified
Conservative management of pelvic organ prolapse
Scoping exercise to discover why there is a limited choice of pessaries in the UK.
Who should manage pessaries, GPs or practice nurses?
Comparison of pessary only versus pessary and PFMT?
Does the teaching of PFMT prior to surgery reduce the risk of further prolapse and the need for 
further prolapse surgery?
Conservative management of urinary problems
Which catheters for IC do individuals prefer? Why?                     
What are the costs and benefits of using silver alloy catheters (changed every 4 weeks) versus 
silicone catheters (changed every 4 weeks) versus hydrogel catheters (changed every 4 weeks)?
Which are the best continence products to use?  
Comparison of patient satisfaction in the use of pads versus PFMT versus surgery for the 
treatment of incontinence?  
Comparison of transverse abdominal exercise and PFMT versus PFMT only for incontinence?
What is the definitive regime for PFMT for incontinence?
(i.e. how many PFME must be done each day?)
Should males and females practice PFMT from puberty onwards?  If so what is the impact on 
later life?
Conservative management of sexual dysfunction
How effective is PFMT in the treatment of sexual dysfunction?  (i.e. for arousal dysfunction, for 
vaginismus, for vulvodynia, for ejaculatory function?)
Is there a role for collaborative practice between psychotherapists and physiotherapists (PFMT) 
for the treatment of orgasmic dysfunction?
Evidence for vaginal dilation and/ or counselling in the treatment of vaginismus?
